blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0599803

EP0599803 - Process for detecting antibodies and antigens [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.02.2001
Database last updated on 03.10.2024
Most recent event   Tooltip21.05.2004Lapse of the patent in a contracting state
New state(s): ES
published on 07.07.2004  [2004/28]
Applicant(s)For all designated states
Sanochemia Pharmazeutika AG
Boltzmannsgasse 11
1090 Wien / AT
[1999/33]
Former [1999/27]For all designated states
Sanochemia Pharmazeutica Aktiengesellschaft
Boltzmannsgasse 11
1090 Wien / AT
Former [1994/22]For all designated states
Waldheim Pharmazeutika Gesellschaft m.b.H.
Landeggerstrasse 7
A-2491 Neufeld/Leitha (Burgenland) / AT
Inventor(s)01 / Schinkinger, Manfred, Dr.
Rudgergasse 9
A-2700 Wiener Neustadt / AT
02 / Korger, Markus, Dr.
Karmelitergasse 7
A-1020 Wien / AT
[1994/22]
Representative(s)Beer, Manfred, et al
BEER & PARTNER PATENTANWÄLTE KG
Lindengasse 8
1070 Wien / AT
[N/P]
Former [1994/22]Beer, Manfred, Dipl.-Ing., et al
Lindengasse 8
A-1070 Wien / AT
Application number, filing date93890224.415.11.1993
[1994/22]
Priority number, dateAT1992000232123.11.1992         Original published format: AT 232192
AT1993000006518.01.1993         Original published format: AT 6593
[1994/22]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0599803
Date:01.06.1994
Language:DE
[1994/22]
Type: B1 Patent specification 
No.:EP0599803
Date:05.04.2000
Language:DE
[2000/14]
Search report(s)(Supplementary) European search report - dispatched on:EP06.04.1994
ClassificationIPC:G01N33/543, G01N33/566, G01N33/58, G01N33/553
[1999/02]
CPC:
G01N33/54313 (EP); G01N33/569 (EP); G01N33/6857 (EP)
Former IPC [1994/22]G01N33/566, G01N33/58, G01N33/553
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   NL,   PT,   SE [1994/22]
TitleGerman:Verfahren zum Nachweisen von Antikörpern und Antigenen[1994/22]
English:Process for detecting antibodies and antigens[1994/22]
French:Procédé de décèlement d'anticorps et d'antigènes[1994/22]
Examination procedure24.06.1994Examination requested  [1994/34]
20.10.1998Despatch of a communication from the examining division (Time limit: M04)
19.11.1998Reply to a communication from the examining division
26.05.1999Despatch of communication of intention to grant (Approval: Yes)
21.06.1999Communication of intention to grant the patent
02.09.1999Fee for grant paid
29.10.1999Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
06.11.1999Fee for publishing/printing paid
Opposition(s)06.01.2001No opposition filed within time limit [2001/12]
Request for further processing for:06.11.1999Request for further processing filed
06.11.1999Full payment received (date of receipt of payment)
Request granted
29.12.1999Decision despatched
Fees paidRenewal fee
08.11.1995Renewal fee patent year 03
30.05.1997Renewal fee patent year 04
30.05.1997Renewal fee patent year 05
07.11.1998Renewal fee patent year 06
07.10.1999Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.11.199604   M06   Fee paid on   30.05.1997
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFR05.04.2000
SE05.04.2000
AT15.11.2000
DK15.11.2000
GB15.11.2000
ES16.11.2000
BE30.11.2000
CH30.11.2000
LI30.11.2000
[2004/28]
Former [2003/45]FR05.04.2000
SE05.04.2000
AT15.11.2000
DK15.11.2000
GB15.11.2000
BE30.11.2000
CH30.11.2000
LI30.11.2000
Former [2002/32]FR05.04.2000
SE05.04.2000
AT15.11.2000
GB15.11.2000
BE30.11.2000
CH30.11.2000
LI30.11.2000
Former [2002/29]SE05.04.2000
AT15.11.2000
GB15.11.2000
BE30.11.2000
CH30.11.2000
LI30.11.2000
Former [2002/15]AT15.11.2000
GB15.11.2000
BE30.11.2000
CH30.11.2000
LI30.11.2000
Former [2002/13]GB15.11.2000
BE30.11.2000
CH30.11.2000
LI30.11.2000
Former [2002/12]GB15.11.2000
BE30.11.2000
Former [2002/03]BE30.11.2000
Documents cited:Search[Y]EP0317001  (JANSSEN PHARMACEUTICA NV [BE]) [Y] 2,6-8,18,31-35,39;
 [DY]WO8906801  (HOLMES MICHAEL JOHN [GB], et al) [DY] 2,6-8,18,31-35,39;
 [A]WO8906543  (GENELABS INC [US])[A] 2,6-8,18,31-35,39
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.